Redhill Biopharma
RDHL
12 hedge funds and large institutions have $20.6M invested in Redhill Biopharma in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.
60% more capital invested
Capital invested by funds: $12.9M → $20.6M (+$7.69M)
50% more funds holding
Funds holding: 8 → 12 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$3.3M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.54M |
| 3 |
O
OrbiMed
New York
|
+$1.14M |
| 4 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$327K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$28.4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $9.98M | +$1.14M | +80 | +13% |
|
|
BC
2
Broadfin Capital
New York
| $7.05M | +$3.3M | +232 | +92% |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $1.57M | +$1.54M | +108 | New |
|
|
CS
4
Candriam SCA
Strassen, Luxembourg,
Luxembourg
| $1.04M | – | – | – |
|
5
Goldman Sachs
New York
| $422K | – | – | – |
|
|
BHB
6
Bank Hapoalim BM
Tel Aviv,
Israel
| $337K | +$327K | +23 | New |
|
|
MMG
7
Monetary Management Group
St Louis,
Missouri
| $57K | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $44K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $38K | +$28.4K | +2 | +200% |
|
10
Bank of America
Charlotte,
North Carolina
| $15K | – | – | – |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $14K | +$14.2K | +1 | New |
|
12
UBS Group
Zurich,
Switzerland
| $11K | +$14.2K | +1 | New |
|
13
Morgan Stanley
New York
| $4K | – | – | – |
|
|
TWA
14
TCI Wealth Advisors
Tucson,
Arizona
| $4K | – | – | – |
|
RDHL Hedge Fund Activity: Q1 2015 in Review
12 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2015, worth a combined $20.6M — up 60% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RDHL positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Broadfin Capital, adding an estimated $3.3M.
- 12 institutional investors held Redhill Biopharma (RDHL) as of Q1 2015, up from 8 in Q4 2014.
- Funds reported $20.6M of Redhill Biopharma stock for Q1 2015, up 60% quarter-over-quarter.
- 4 funds opened new Redhill Biopharma positions in Q1 2015 and 0 closed out, a net change of +4 holders.
- The largest Redhill Biopharma buyer in Q1 2015 was Broadfin Capital, an estimated $3.3M added.
Based on aggregated 13F filings for Q1 2015.